Madrigal Pharmaceuticals (MDGL)
Commercializes Rezdiffra and develops combination therapies for MASH.
$511.50
vs last close−7.33 (−1.41%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.86
Revenue estimate
$404.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported−$2.71−$3.32−$1.90−$5.08−$2.57−$3.25−$1.99Pending
Estimate−$4.32−$3.62−$3.48−$2.04$0.04−$3.61−$2.68−$0.86
Surprise+37.3%+8.3%+45.4%−149.4%−6,525.0%+10.0%+25.7%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$103.3M$137.3M$212.8M$287.3M$321.1M$311.3M$364.3MPending
Estimate$97.8M$158.9M$243.5M$245.0M$312.5M$301.1M$352.1M$404.2M
Surprise+5.6%−13.6%−12.6%+17.3%+2.8%+3.4%+3.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $3.45 | — | — |
| Sep 2027 | $2.07 | — | — |
| Jun 2027 | $1.02 | — | — |
| Mar 2027 | −$0.15 | — | — |
| Dec 2026 | −$0.19 | — | — |
| Nov 2026 | −$0.86 | — | — |
| Jul 2026 | −$2.68 | −$1.99 | +25.7% |
| May 2026 | −$3.61 | −$3.25 | +10.0% |
| Feb 2026 | $0.04 | −$2.57 | −6,525.0% |
| Nov 2025 | −$2.04 | −$5.08 | −149.4% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Apr 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $3.45 | — | — | $645.7M | — | — | — |
| Sep 2027 | $2.07 | — | — | $572.9M | — | — | — |
| Jun 2027 | $1.02 | — | — | $518.0M | — | — | — |
| Mar 2027 | −$0.15 | — | — | $468.3M | — | — | — |
| Dec 2026 | −$0.19 | — | — | $443.8M | — | — | — |
| Nov 3, 2026 | −$0.86 | — | — | $404.2M | — | — | — |
| Jul 30, 2026 | −$2.68 | −$1.99 | +25.7% | $352.1M | $364.3M | +3.5% | −9.8% |
| May 6, 2026 | −$3.61 | −$3.25 | +10.0% | $301.1M | $311.3M | +3.4% | +7.4% |
| Feb 19, 2026 | $0.04 | −$2.57 | −6,525.0% | $312.5M | $321.1M | +2.8% | −11.1% |
| Nov 4, 2025 | −$2.04 | −$5.08 | −149.4% | $245.0M | $287.3M | +17.3% | +7.8% |
| Aug 5, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 26, 2025 | |||||||
| Oct 31, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 6, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 9, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 6, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 13, 2018 | |||||||
| Nov 9, 2017 | |||||||
| Aug 10, 2017 | |||||||
| May 11, 2017 | |||||||
| Apr 3, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Jul 20, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Nov 5, 2015 | |||||||
| Aug 6, 2015 |